RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 87 filers reported holding RELMADA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $95,145 | +22.0% | 31,715 | 0.0% | 0.00% | +33.3% |
| Q2 2023 | $78,019 | +14.3% | 31,715 | +5.0% | 0.00% | 0.0% |
| Q1 2023 | $68,286 | -3.2% | 30,215 | +49.5% | 0.00% | 0.0% |
| Q4 2022 | $70,551 | -81.3% | 20,215 | +97.9% | 0.00% | -87.0% |
| Q3 2022 | $377,000 | +94.3% | 10,215 | 0.0% | 0.02% | +53.3% |
| Q2 2022 | $194,000 | -89.1% | 10,215 | -81.6% | 0.02% | -78.9% |
| Q2 2021 | $1,778,000 | -9.1% | 55,556 | 0.0% | 0.07% | -17.4% |
| Q1 2021 | $1,956,000 | +9.8% | 55,556 | 0.0% | 0.09% | 0.0% |
| Q4 2020 | $1,782,000 | -82.4% | 55,556 | -79.4% | 0.09% | -82.4% |
| Q3 2020 | $10,151,000 | -19.7% | 269,839 | -4.5% | 0.49% | -27.1% |
| Q2 2020 | $12,646,000 | +31.2% | 282,592 | 0.0% | 0.67% | +7.7% |
| Q1 2020 | $9,639,000 | -12.5% | 282,592 | 0.0% | 0.62% | +18.2% |
| Q4 2019 | $11,021,000 | – | 282,592 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |